• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链脂肪酸氧化障碍成纤维细胞中的不同脂质特征。

Different Lipid Signature in Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders.

机构信息

Department of General Pediatrics, Adolescent Medicine and Neonatology, Faculty of Medicine, Medical Centre-University of Freiburg, 79106 Freiburg, Germany.

Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany.

出版信息

Cells. 2021 May 18;10(5):1239. doi: 10.3390/cells10051239.

DOI:10.3390/cells10051239
PMID:34069977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8157847/
Abstract

Long-chain fatty acid oxidation disorders (lc-FAOD) are a group of diseases affecting the degradation of long-chain fatty acids. In order to investigate the disease specific alterations of the cellular lipidome, we performed undirected lipidomics in fibroblasts from patients with carnitine palmitoyltransferase II, very long-chain acyl-CoA dehydrogenase, and long-chain 3-hydroxyacyl-CoA dehydrogenase. We demonstrate a deep remodeling of mitochondrial cardiolipins. The aberrant phosphatidylcholine/phosphatidylethanolamine ratio and the increased content of plasmalogens and of lysophospholipids support the theory of an inflammatory phenotype in lc-FAOD. Moreover, we describe increased ratios of sphingomyelin/ceramide and sphingomyelin/hexosylceramide in LCHAD deficiency which may contribute to the neuropathic phenotype of LCHADD/mitochondrial trifunctional protein deficiency.

摘要

长链脂肪酸氧化障碍(lc-FAOD)是一组影响长链脂肪酸降解的疾病。为了研究细胞脂质组的疾病特异性改变,我们对肉碱棕榈酰基转移酶 II、极长链酰基辅酶 A 脱氢酶和长链 3-羟基酰基辅酶 A 脱氢酶患者的成纤维细胞进行了非定向脂质组学分析。我们证明了线粒体心磷脂的深度重塑。异常的磷脂酰胆碱/磷脂酰乙醇胺比值以及血小板质和溶血磷脂的含量增加支持了 lc-FAOD 中炎症表型的理论。此外,我们描述了 LCHAD 缺乏症中鞘磷脂/神经酰胺和鞘磷脂/己糖神经酰胺比值增加,这可能有助于 LCHADD/三功能蛋白缺乏症的神经病变表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a3c/8157847/abdbc4629aed/cells-10-01239-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a3c/8157847/03ee13c6bb8d/cells-10-01239-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a3c/8157847/d4d45d7c5e25/cells-10-01239-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a3c/8157847/6ab0d0bad7f0/cells-10-01239-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a3c/8157847/354af11e60a7/cells-10-01239-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a3c/8157847/abdbc4629aed/cells-10-01239-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a3c/8157847/03ee13c6bb8d/cells-10-01239-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a3c/8157847/d4d45d7c5e25/cells-10-01239-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a3c/8157847/6ab0d0bad7f0/cells-10-01239-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a3c/8157847/354af11e60a7/cells-10-01239-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a3c/8157847/abdbc4629aed/cells-10-01239-g005.jpg

相似文献

1
Different Lipid Signature in Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders.长链脂肪酸氧化障碍成纤维细胞中的不同脂质特征。
Cells. 2021 May 18;10(5):1239. doi: 10.3390/cells10051239.
2
Unique plasma metabolomic signatures of individuals with inherited disorders of long-chain fatty acid oxidation.患有长链脂肪酸氧化遗传性疾病个体的独特血浆代谢组学特征。
J Inherit Metab Dis. 2016 May;39(3):399-408. doi: 10.1007/s10545-016-9915-3. Epub 2016 Feb 23.
3
Blood cytokine patterns suggest a modest inflammation phenotype in subjects with long-chain fatty acid oxidation disorders.血液细胞因子模式表明,患有长链脂肪酸氧化障碍的受试者存在适度的炎症表型。
Physiol Rep. 2019 Mar;7(6):e14037. doi: 10.14814/phy2.14037.
4
Should the beneficial impact of bezafibrate on fatty acid oxidation disorders be questioned?非诺贝特对脂肪酸氧化紊乱的有益影响是否值得质疑?
J Inherit Metab Dis. 2015 Mar;38(2):371-2. doi: 10.1007/s10545-014-9775-7. Epub 2014 Oct 14.
5
Lipidomic and Proteomic Alterations Induced by Even and Odd Medium-Chain Fatty Acids on Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders.长链脂肪酸氧化障碍患者成纤维细胞中偶数和奇数中链脂肪酸引起的脂质组学和蛋白质组学改变。
Int J Mol Sci. 2021 Sep 29;22(19):10556. doi: 10.3390/ijms221910556.
6
Long-chain fatty acid oxidation during early human development.人类早期发育过程中的长链脂肪酸氧化
Pediatr Res. 2005 Jun;57(6):755-9. doi: 10.1203/01.PDR.0000161413.42874.74. Epub 2005 Apr 21.
7
Muscle MRI in patients with long-chain fatty acid oxidation disorders.长链脂肪酸氧化障碍患者的肌肉磁共振成像
J Inherit Metab Dis. 2014 May;37(3):405-13. doi: 10.1007/s10545-013-9666-3. Epub 2013 Dec 5.
8
Medium branched chain fatty acids improve the profile of tricarboxylic acid cycle intermediates in mitochondrial fatty acid β-oxidation deficient cells: A comparative study.中链支链脂肪酸改善线粒体脂肪酸β氧化缺陷细胞三羧酸循环中间产物的特征:一项比较研究。
J Inherit Metab Dis. 2022 May;45(3):541-556. doi: 10.1002/jimd.12480. Epub 2022 Feb 2.
9
Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.利用替代前体和成纤维细胞中的酰基肉碱谱分析对长链脂肪酸氧化障碍进行鉴别诊断。
Mol Genet Metab. 2006 Jan;87(1):40-7. doi: 10.1016/j.ymgme.2005.09.018. Epub 2005 Nov 16.
10
Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: implications for medium chain triglyceride dietary treatment of LCHAD deficiency.长链L-3-羟酰基辅酶A脱氢酶(LCHAD)和线粒体三功能蛋白缺陷的皮肤成纤维细胞培养基中3-羟基脂肪酸的积累:对LCHAD缺乏症中链甘油三酯饮食治疗的意义。
Pediatr Res. 2003 May;53(5):783-7. doi: 10.1203/01.PDR.0000059748.67987.1F. Epub 2003 Mar 5.

引用本文的文献

1
Plasma Metabolomics, Lipidomics, and Acylcarnitines Are Associated With Vision and Genotype but Not With Dietary Intake in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHADD).在长链3-羟基酰基辅酶A脱氢酶缺乏症(LCHADD)中,血浆代谢组学、脂质组学和酰基肉碱与视力和基因型相关,但与饮食摄入量无关。
J Inherit Metab Dis. 2025 Jul;48(4):e70060. doi: 10.1002/jimd.70060.
2
Circulatory response to exercise relative to oxygen uptake assessed in the follow-up of patients with fatty acid beta-oxidation disorders.在脂肪酸β-氧化障碍患者随访中评估的运动时相对于摄氧量的循环反应。
J Inherit Metab Dis. 2025 Jan;48(1):e12819. doi: 10.1002/jimd.12819. Epub 2024 Dec 9.
3

本文引用的文献

1
Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders.使用三庚酸甘油酯作为长链脂肪酸氧化障碍的回补疗法的生理学观点。
Front Genet. 2021 Jan 15;11:598760. doi: 10.3389/fgene.2020.598760. eCollection 2020.
2
Effect of Expression of Human Glucosylceramidase 2 Isoforms on Lipid Profiles in COS-7 Cells.人葡糖神经酰胺酶2亚型表达对COS-7细胞脂质谱的影响。
Metabolites. 2020 Nov 27;10(12):488. doi: 10.3390/metabo10120488.
3
Metabolic Alterations Caused by Defective Cardiolipin Remodeling in Inherited Cardiomyopathies.
Mitochondrial bioenergetics and cardiolipin remodeling abnormalities in mitochondrial trifunctional protein deficiency.
线粒体三功能蛋白缺陷中的线粒体生物能学和心磷脂重塑异常。
JCI Insight. 2024 Sep 10;9(17):e176887. doi: 10.1172/jci.insight.176887.
4
Disorders of fatty acid homeostasis.脂肪酸稳态紊乱。
J Inherit Metab Dis. 2025 Jan;48(1):e12734. doi: 10.1002/jimd.12734. Epub 2024 May 1.
5
An evaluation of untargeted metabolomics methods to characterize inborn errors of metabolism.针对代谢缺陷的非靶向代谢组学方法的评估。
Mol Genet Metab. 2024 Jan;141(1):108115. doi: 10.1016/j.ymgme.2023.108115. Epub 2023 Dec 15.
6
Fatty Acids Profile and the Relevance of Membranes as the Target of Nutrition-Based Strategies in Atopic Dermatitis: A Narrative Review.脂肪酸谱与细胞膜作为特应性皮炎营养策略靶点的相关性:叙述性综述。
Nutrients. 2023 Sep 4;15(17):3857. doi: 10.3390/nu15173857.
7
A Distinctive Metabolomics Profile and Potential Biomarkers for Very Long Acylcarnitine Dehydrogenase Deficiency (VLCADD) Diagnosis in Newborns.新生儿极长链酰基辅酶A脱氢酶缺乏症(VLCADD)诊断的独特代谢组学特征及潜在生物标志物
Metabolites. 2023 Jun 5;13(6):725. doi: 10.3390/metabo13060725.
8
Lipidomics-Paving the Road towards Better Insight and Precision Medicine in Rare Metabolic Diseases.脂质组学——为罕见代谢疾病的深入了解和精准医学铺平道路。
Int J Mol Sci. 2023 Jan 15;24(2):1709. doi: 10.3390/ijms24021709.
9
Synthetic mRNA rescues very long-chain acyl-CoA dehydrogenase deficiency in patient fibroblasts and a murine model.合成 mRNA 可挽救患者成纤维细胞和小鼠模型中的极长链酰基辅酶 A 脱氢酶缺乏症。
Mol Genet Metab. 2023 Jan;138(1):106982. doi: 10.1016/j.ymgme.2022.106982. Epub 2022 Dec 23.
10
Mitochondrial Fatty Acid β-Oxidation Disorders: From Disease to Lipidomic Studies-A Critical Review.线粒体脂肪酸 β-氧化障碍:从疾病到脂质组学研究——综述。
Int J Mol Sci. 2022 Nov 11;23(22):13933. doi: 10.3390/ijms232213933.
遗传性心肌病中因心磷脂重塑缺陷导致的代谢改变。
Life (Basel). 2020 Nov 11;10(11):277. doi: 10.3390/life10110277.
4
Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.鞘脂代谢在中枢神经系统中的改变:肌萎缩侧索硬化症(ALS)和其他神经退行性疾病。
Semin Cell Dev Biol. 2021 Apr;112:82-91. doi: 10.1016/j.semcdb.2020.10.008. Epub 2020 Nov 5.
5
Cardiolipin, the Mitochondrial Signature Lipid: Implication in Cancer.心磷脂,线粒体特征脂质:在癌症中的意义。
Int J Mol Sci. 2020 Oct 28;21(21):8031. doi: 10.3390/ijms21218031.
6
Sex-specific perturbation of complex lipids in response to medium-chain fatty acids in very long-chain acyl-CoA dehydrogenase deficiency.对长链酰基辅酶 A 脱氢酶缺乏症中中链脂肪酸的反应中,复杂脂质的性别特异性扰动。
FEBS J. 2020 Aug;287(16):3511-3525. doi: 10.1111/febs.15221. Epub 2020 Feb 6.
7
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes.TFPa/HADHA 对于人类心肌细胞中的脂肪酸 β-氧化和心磷脂重塑是必需的。
Nat Commun. 2019 Oct 11;10(1):4671. doi: 10.1038/s41467-019-12482-1.
8
The fate of medium-chain fatty acids in very long-chain acyl‑CoA dehydrogenase deficiency (VLCADD): A matter of sex?中链脂肪酸在极长链酰基辅酶 A 脱氢酶缺乏症(VLCADD)中的命运:性别问题?
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Nov;1864(11):1591-1605. doi: 10.1016/j.bbalip.2019.08.001. Epub 2019 Aug 5.
9
Alteration of Sphingolipids in Biofluids: Implications for Neurodegenerative Diseases.生物体液中神经酰胺代谢物的改变:对神经退行性疾病的影响。
Int J Mol Sci. 2019 Jul 21;20(14):3564. doi: 10.3390/ijms20143564.
10
Role of Cardiolipin in Mitochondrial Function and Dynamics in Health and Disease: Molecular and Pharmacological Aspects.心磷脂在健康和疾病中的线粒体功能和动态中的作用:分子和药理学方面。
Cells. 2019 Jul 16;8(7):728. doi: 10.3390/cells8070728.